"Presynaptic" inhibition in spasticity and the effect of beta(4-chlorophenyl)GABA.
D000328:Adult; D000613:Aminobutyrates / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002722:Chlorobenzenes / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004576:Electromyography; D006801:Humans; D009132:Muscles / Q000503:physiopathology; D010919:Placebos; D012023:Reflex, Monosynaptic / Q000187:drug effects*; D013035:Spasm / Q000188:drug therapy* / Q000503:physiopathology; D014732:Vibration
D000613:Aminobutyrates; D002722:Chlorobenzenes; D010919:Placebos